cisapride has been researched along with celecoxib in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Henney, JE | 1 |
Clary, EM; de la Fuente, SG; Eubanks, WS; Harris, MB; Lawson, DC; McMahon, RL; Pappas, TN; Reynolds, JD | 1 |
Bouras, EP; Burton, DD; Camilleri, M; Stephens, DA; Thomforde, GM | 1 |
1 trial(s) available for cisapride and celecoxib
Article | Year |
---|---|
Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans.
Topics: Adolescent; Adult; Aged; Celecoxib; Cisapride; Cyclooxygenase Inhibitors; Female; Gastric Emptying; Gastrointestinal Agents; Gastrointestinal Transit; Humans; Intestine, Small; Lactones; Male; Middle Aged; Pyrazoles; Radionuclide Imaging; Sulfonamides; Sulfones | 2004 |
4 other study(ies) available for cisapride and celecoxib
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
From the Food and Drug Administration.
Topics: Adenomatous Polyposis Coli; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Bexarotene; Celecoxib; Cisapride; Contraindications; Cyclooxygenase Inhibitors; Drug Labeling; Gastrointestinal Agents; Humans; Lymphoma, T-Cell, Cutaneous; Pyrazoles; Receptors, Retinoic Acid; Sulfonamides; Tetrahydronaphthalenes | 2000 |
Celecoxib (celebrex) increases canine lower esophageal sphincter pressure.
Topics: Animals; Celecoxib; Cisapride; Cyclooxygenase Inhibitors; Dogs; Esophagogastric Junction; Female; Gastrointestinal Agents; Pressure; Pyrazoles; Sulfonamides | 2002 |